ArticleJournal of Crohn's & colitis2019

Proactive Therapeutic Drug Monitoring of Adalimumab Is Associated With Better Long-term Outcomes Compared With Standard of Care in Patients With Inflammatory Bowel Disease.

Konstantinos Papamichael et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.